A Novel Acuity Testing Method
2 other identifiers
observational
500
1 country
1
Brief Summary
The purpose of this protocol is to develop a valid, reliable, better standardized, and more efficient test of visual acuity (ability to see fine details) for use in clinical trials. Recent improvements in computer video hardware permit calibration, characterization, and accurate rendering of eye-chart-quality letters. The computer can then be used to measure acuity. The modified binary search (MOBS) testing strategy is one method of computer-based testing. This study will compare the accuracy, precision, stability and utility of the MOBS technique with the eye chart method used in the National Eye Institute's Early Treatment for Diabetic Retinopathy Study (ETDRS). The ETDRS method is currently the gold standard for acuity testing in clinical trials. Study subjects will include NEI clinic patients between 7 and 90 years of age with or without eye disease. Eye diseases include poor visual acuity, age-related macular degeneration, cataract, optic nerve abnormality, corneal abnormality, uveitis, glaucoma, other retinal or choroid abnormality, amblyopia or other eye disease. Participants will have their vision tested in each eye using both the ETDRS eye chart method and the MOBS method. The ETDRS method will require subjects to read all the letters on the chart until they can no longer see the details. For the MOBS method, they will read a single letter at a time that will appear on the computer screen. After reading each letter, a new letter will be presented that is either bigger or smaller in size. After completing the last acuity test, participants will fill out a questionnaire regarding their preference for one test type over the other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2001
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2001
CompletedFirst Submitted
Initial submission to the registry
April 3, 2001
CompletedFirst Posted
Study publicly available on registry
April 4, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2002
CompletedMarch 4, 2008
October 1, 2002
April 3, 2001
March 3, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Subjects will include clinic patients selected with priority for those with poor visual acuity and based on maintaining smooth clinic functioning.
- Subjects will be classified into those with or without ocular disease, high refractive error, AMD, cataract, optic nerve abnormality, corneal abnormality, uveitis, glaucoma, other retinal/choroid abnormality, amblyopia, or a specified other ocular disease.
- Patients with low vision will be oversampled in order to test within a large range of possible end points.
- All subjects will have the ability to understand and sign an informed consent form obtained prior to enrollment.
- Enrolled participants will range in age from 7 years to 90 years.
You may not qualify if:
- Illiteracy (inability to identify letters of the Latin alphabet)
- Children younger than 7, due to cognitive inability to undergo specific tests and procedures required in the protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Eye Institute (NEI)
Bethesda, Maryland, 20892, United States
Related Publications (2)
Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997 Feb;38(2):413-25.
PMID: 9040475BACKGROUNDFerris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982 Jul;94(1):91-6.
PMID: 7091289BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 3, 2001
First Posted
April 4, 2001
Study Start
March 1, 2001
Study Completion
October 1, 2002
Last Updated
March 4, 2008
Record last verified: 2002-10